The Breast Biopsy Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Breast Biopsy Market?
The breast biopsy market has seen significant expansion in past years, escalating from a value of $1.42 billion in 2024 to $1.53 billion in 2025. This growth exhibits a compound annual growth rate (CAGR) of 7.6%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Breast Biopsy Industry?
The Breast Biopsy Global Market is projected to reach a size of $2.03 billion in 2029, growing at a compound annual growth rate (CAGR) of 7.3%.
Download Your Free Sample of the 2025 Breast Biopsy Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Breast Biopsy Market?
The key drivers in the breast biopsy market are:
• Infrastructural development in the healthcare sector
• Growth of personalized medicine
• Increasing healthcare access in developing regions
• Regulatory support and reimbursement policies well in place
• Rise of telemedicine and remote diagnostics.
Global Market Segmentation: Identifying Major Breast Biopsy Industry Segments
The breast biopsymarket covered in this report is segmented –
1) By Type: Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Other Types
2) By Image Guided Technology: Magnetic Resonance Imaging (MRI) Guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, Computed Tomography (CT) Guided Biopsy, Other Image Guided Breast Biopsy
3) By Procedure: Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy
4) By Application: Hospitals, Clinics, Diagnostic Centers, Other Applications
Pre-order the 2025 Breast Biopsy Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Breast Biopsy Market?
The key trends in the breast biopsy market are:
• The adoption of robotics in biopsy procedures is becoming a significant trend.
• There is an emerging trend for home-based biopsy kits.
• The significance of genomic biopsies is steadily increasing.
• The industry is shifting towards patient-centered care models, the use of blockchain for enhanced data security, and the emphasis on post-biopsy monitoring tools.
Who Are the Top Competitors & Leading Players in the Breast Biopsy Market?
Major companies in the breast biopsy market are:
• Medtronic PLC
• Siemens Healthineers AG
• Fujifilm Holdings Corporation
• Becton Dickinson and Company (BD)
• Koninklijke Philips
• GE HealthCare Technologies Inc.
• Hologic Inc.
• The Cooper Companies Inc.
• Merit Medical Systems
• Argon Medical Devices
• Canon Medical Systems Corporation
• Devicor Medical Products Inc.
• Mermaid Medical Group
• Planmed Oy
• Menarini-Silicon Biosystems
• Seno Medical Instruments Inc.
• Surgical Innovations Group
• Sterylab Srl
• Dilon Technologies Inc.
• INRAD Inc.
• Promaxo Inc.
Regional Dominance: Which Area Leads the Global Breast Biopsy Market?
North America was the largest region in the breast biopsy market in 2024
